CALYXT INC (CLXT) Stock Price, Quote, News and Overview
NASDAQ:CLXT - Nasdaq - US13173L2060 - Common Stock - Currency: USD
CLXT Quote, Performance and Key Statistics
6.3
+0.33 (+5.53%)
The current stock price of CLXT is 6.3 USD. In the past month the price increased by 99.37%. In the past year, price increased by 107.37%.
CLXT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About CLXT
Company Profile
Calyxt Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Roseville, Minnesota and currently employs 25 full-time employees. The company went IPO on 2017-07-20. Calyxt, Inc. is a plant-based synthetic biology company. The firm is focused on research and development, including gene editing, plant breeding, and trait development. The company specializes in engineering plant metabolisms. The firm leverages its PlantSpring technology platform to engineer plant metabolism to produce sustainable materials and products for use in helping customers meet. The firm operates through the development and commercialization of products derived from plant cells. Its platform provides plant-based synthetic biology solutions to customers across multiple industries. The firm has engineered plant metabolism into products including soybeans with improved fatty-acid profiles and alfalfa able to be better digested by livestock. Its product pipeline includes hemp, winter oats, and high saturated fat soybeans. Hemp serves a range of varieties of materials science needs, including strengthening plastics and reducing petroleum-based content.
Company Info
CALYXT INC
2800 Mount Ridge Rd
Roseville MINNESOTA 55113 US
CEO: Yves Ribeill
Employees: 25
Company Website: https://calyxt.com/
Phone: 16516832807.0
CALYXT INC / CLXT FAQ
What is the stock price of CALYXT INC today?
The current stock price of CLXT is 6.3 USD. The price increased by 5.53% in the last trading session.
What is the ticker symbol for CALYXT INC stock?
The exchange symbol of CALYXT INC is CLXT and it is listed on the Nasdaq exchange.
On which exchange is CLXT stock listed?
CLXT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for CALYXT INC stock?
8 analysts have analysed CLXT and the average price target is 36.98 USD. This implies a price increase of 486.9% is expected in the next year compared to the current price of 6.3. Check the CALYXT INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is CALYXT INC worth?
CALYXT INC (CLXT) has a market capitalization of 31.33M USD. This makes CLXT a Nano Cap stock.
How many employees does CALYXT INC have?
CALYXT INC (CLXT) currently has 25 employees.
Is CALYXT INC (CLXT) expected to grow?
The Revenue of CALYXT INC (CLXT) is expected to grow by 38.59% in the next year. Check the estimates tab for more information on the CLXT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy CALYXT INC (CLXT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CLXT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CLXT, evaluating the profitability, health, valuation and growth aspects
- CALYXT INC (CLXT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- CALYXT INC (CLXT) Sales and EPS estimates to see what analysts future expectations are.
- CALYXT INC (CLXT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- CALYXT INC (CLXT) Insider and Institutional Ownership to learn about the owners and their transactions.
- CALYXT INC (CLXT) Stock Chart to make your own analysis
- CALYXT INC (CLXT) Latest news and press-releases to stay up to date.
Does CALYXT INC (CLXT) stock pay dividends?
CLXT does not pay a dividend.
When does CALYXT INC (CLXT) report earnings?
CALYXT INC (CLXT) will report earnings on 2023-08-02, after the market close.
What is the Price/Earnings (PE) ratio of CALYXT INC (CLXT)?
CALYXT INC (CLXT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.04).
CLXT Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to CLXT. When comparing the yearly performance of all stocks, CLXT is one of the better performing stocks in the market, outperforming 97.73% of all stocks.
CLXT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CLXT. CLXT has a bad profitability rating. Also its financial health evaluation is rather negative.
CLXT Financial Highlights
Over the last trailing twelve months CLXT reported a non-GAAP Earnings per Share(EPS) of -3.04. The EPS decreased by -289.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
CLXT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 48% to CLXT. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 82.92% and a revenue growth 38.59% for CLXT